211 related articles for article (PubMed ID: 2706627)
1. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Musgrove EA; Wakeling AE; Sutherland RL
Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells.
Sutherland RL; Watts CK; Hall RE; Ruenitz PC
J Steroid Biochem; 1987; 27(4-6):891-7. PubMed ID: 3695509
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
[TBL] [Abstract][Full Text] [Related]
4. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
[TBL] [Abstract][Full Text] [Related]
5. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Osborne CK; Boldt DH; Estrada P
Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
[TBL] [Abstract][Full Text] [Related]
6. Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells.
Wakeling AE; Newboult E; Peters SW
J Mol Endocrinol; 1989 May; 2(3):225-34. PubMed ID: 2665780
[TBL] [Abstract][Full Text] [Related]
7. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
Wilcken NR; Prall OW; Musgrove EA; Sutherland RL
Clin Cancer Res; 1997 Jun; 3(6):849-54. PubMed ID: 9815758
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
9. Different points of action of retinoids and anti-estrogens in G1 phase identified in synchronized T-47D breast cancer cells.
Wilcken NR; Musgrove EA; Sutherland RL
Int J Cancer; 1997 Jan; 70(3):291-6. PubMed ID: 9033630
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
Wilcken NR; Sarcevic B; Musgrove EA; Sutherland RL
Cell Growth Differ; 1996 Jan; 7(1):65-74. PubMed ID: 8788034
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro.
Murphy LC; Sutherland RL
Endocrinology; 1985 Mar; 116(3):1071-8. PubMed ID: 3971898
[TBL] [Abstract][Full Text] [Related]
15. Influence of cyclopropyl antiestrogens on the cell cycle kinetics of MCF-7 human breast cancer cells.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1995; 15(6B):2529-32. PubMed ID: 8669818
[TBL] [Abstract][Full Text] [Related]
16. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
Zajchowski DA; Sager R; Webster L
Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells.
Nolan E; Donepudi M; VanWeelden K; Flanagan L; Welsh J
Mol Cell Biochem; 1998 Nov; 188(1-2):13-20. PubMed ID: 9823006
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L
Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916
[TBL] [Abstract][Full Text] [Related]
19. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenesis by antiestrogens.
Gagliardi A; Collins DC
Cancer Res; 1993 Feb; 53(3):533-5. PubMed ID: 7678775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
